Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 308

1.

RNA Genetic Testing Identifies Germline Pathogenic MSH2 Tandem Duplications in Lynch Syndrome Patients.

Conner BR, Hernandez F, Souders B, Landrith T, Boland CR, Karam R.

Gastroenterology. 2019 Jan 30. pii: S0016-5085(19)30343-9. doi: 10.1053/j.gastro.2019.01.248. [Epub ahead of print] No abstract available.

2.

Lynch-like syndrome is as frequent as Lynch syndrome in early-onset non-familial non-polyposis colorectal cancer.

Antelo M, Golubicki M, Roca E, Mendez G, Carballido M, Iseas S, Cuatrecasas M, Moreira L, Sanchez A, Carballal S, Castells A, Boland CR, Goel A, Balaguer F.

Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32160. [Epub ahead of print]

PMID:
30693488
3.

Characterization and Identification of Colorectal Cancer in Persons Younger Than 50 Years.

Strum WB, Boland CR.

Clin Gastroenterol Hepatol. 2018 Dec 10. pii: S1542-3565(18)31355-7. doi: 10.1016/j.cgh.2018.12.003. [Epub ahead of print]

PMID:
30543950
4.

EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome.

Pathak SJ, Mueller JL, Okamoto K, Das B, Hertecant J, Greenhalgh L, Cole T, Pinsk V, Yerushalmi B, Gurkan OE, Yourshaw M, Hernandez E, Oesterreicher S, Naik S, Sanderson IR, Axelsson I, Agardh D, Boland CR, Martin MG, Putnam CD, Sivagnanam M.

Hum Mutat. 2019 Feb;40(2):142-161. doi: 10.1002/humu.23688. Epub 2018 Nov 29.

PMID:
30461124
5.

Diagnosis of Malignant Potential in Mucinous Peritoneal Neoplasms by Characterization of Mucin Carbohydrate Structure.

Clark LA, Ghazi A, Gaffney K, Soto R, Agarwal A, Carmack S, Boland CR.

Cell Mol Gastroenterol Hepatol. 2018 Mar 10;6(1):108-109.e2. doi: 10.1016/j.jcmgh.2018.02.012. eCollection 2018. No abstract available.

6.

Reply.

Toiyama Y, Okugawa Y, Boland CR, Goel A.

Gastroenterology. 2018 Jun;154(8):2274-2275. doi: 10.1053/j.gastro.2018.05.013. Epub 2018 May 8. No abstract available.

PMID:
29750909
7.

TFAP2E Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal Cancer.

Murcia O, Jover R, Egoavil C, Perez-Carbonell L, Juárez M, Hernández-Illán E, Rojas E, Alenda C, Balaguer F, Andreu M, Llor X, Castells A, Boland CR, Goel A.

Clin Cancer Res. 2018 Jun 15;24(12):2820-2827. doi: 10.1158/1078-0432.CCR-17-2940. Epub 2018 Mar 13.

PMID:
29535127
8.

Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.

Boland PM, Yurgelun MB, Boland CR.

CA Cancer J Clin. 2018 May;68(3):217-231. doi: 10.3322/caac.21448. Epub 2018 Feb 27. Review.

9.

A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer.

Yamada A, Yu P, Lin W, Okugawa Y, Boland CR, Goel A.

Sci Rep. 2018 Jan 12;8(1):575. doi: 10.1038/s41598-017-18407-6.

10.

Accuracy of four mononucleotide-repeat markers for the identification of DNA mismatch-repair deficiency in solid tumors.

Takehara Y, Nagasaka T, Nyuya A, Haruma T, Haraga J, Mori Y, Nakamura K, Fujiwara T, Boland CR, Goel A.

J Transl Med. 2018 Jan 12;16(1):5. doi: 10.1186/s12967-017-1376-4.

11.

Erratum to: Non-coding RNA: It's Not Junk.

Boland CR.

Dig Dis Sci. 2017 Nov;62(11):3260. doi: 10.1007/s10620-017-4746-0. No abstract available.

PMID:
28879425
12.

Effect of aspirin on tumour cell colony formation and evolution.

Wodarz D, Goel A, Boland CR, Komarova NL.

J R Soc Interface. 2017 Sep;14(134). pii: 20170374. doi: 10.1098/rsif.2017.0374.

13.

A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.

Toiyama Y, Okugawa Y, Tanaka K, Araki T, Uchida K, Hishida A, Uchino M, Ikeuchi H, Hirota S, Kusunoki M, Boland CR, Goel A.

Gastroenterology. 2017 Dec;153(6):1634-1646.e8. doi: 10.1053/j.gastro.2017.08.037. Epub 2017 Aug 25.

14.

Mutational cascades in cancer.

Boland CR, Yurgelun MB.

Oncotarget. 2017 Jun 27;8(26):41784-41785. doi: 10.18632/oncotarget.18481. No abstract available.

15.

Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.

Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ.

Gastroenterology. 2017 Jul;153(1):307-323. doi: 10.1053/j.gastro.2017.05.013. Epub 2017 Jun 9.

PMID:
28600072
16.

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer.

Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ.

Gastrointest Endosc. 2017 Jul;86(1):18-33. doi: 10.1016/j.gie.2017.04.003. Epub 2017 Jun 6. No abstract available.

PMID:
28600070
17.

Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.

Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ.

Am J Gastroenterol. 2017 Jul;112(7):1016-1030. doi: 10.1038/ajg.2017.174. Epub 2017 Jun 6. Review.

PMID:
28555630
18.

Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Durno C, Boland CR, Cohen S, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ, Rex DK.

Gastroenterology. 2017 May;152(6):1605-1614. doi: 10.1053/j.gastro.2017.02.011. Epub 2017 Mar 28. Review.

PMID:
28363489
19.

Recommendations on surveillance and management of biallelic mismatch repair deficiency (BMMRD) syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer.

Durno C, Boland CR, Cohen S, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ, Rex DK.

Gastrointest Endosc. 2017 May;85(5):873-882. doi: 10.1016/j.gie.2017.03.015. Epub 2017 Mar 28. No abstract available.

PMID:
28363411
20.

Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-society Task Force on Colorectal Cancer.

Durno C, Boland CR, Cohen S, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ, Rex DK.

J Pediatr Gastroenterol Nutr. 2017 May;64(5):836-843. doi: 10.1097/MPG.0000000000001578. No abstract available.

PMID:
28353469
21.

Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Durno C, Boland CR, Cohen S, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ, Rex DK.

Am J Gastroenterol. 2017 May;112(5):682-690. doi: 10.1038/ajg.2017.105. Epub 2017 Mar 28.

PMID:
28349994
22.

Historical Perspective on Familial Gastric Cancer.

Boland CR, Yurgelun MB.

Cell Mol Gastroenterol Hepatol. 2017 Feb 28;3(2):192-200. doi: 10.1016/j.jcmgh.2016.12.003. eCollection 2017 Mar. Review.

23.

Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells.

Zumwalt TJ, Wodarz D, Komarova NL, Toden S, Turner J, Cardenas J, Burn J, Chan AT, Boland CR, Goel A.

Cancer Prev Res (Phila). 2017 Mar;10(3):208-218. doi: 10.1158/1940-6207.CAPR-16-0175. Epub 2017 Feb 2.

24.

Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implications.

Shia J, Schultz N, Kuk D, Vakiani E, Middha S, Segal NH, Hechtman JF, Berger MF, Stadler ZK, Weiser MR, Wolchok JD, Boland CR, Gönen M, Klimstra DS.

Mod Pathol. 2017 Apr;30(4):599-609. doi: 10.1038/modpathol.2016.198. Epub 2016 Dec 16.

25.

"New" Cancer Genes and Inherited Colorectal Cancer Risk: Caveat Emptor.

Yurgelun MB, Boland CR.

Gastroenterology. 2017 Jan;152(1):12-13. doi: 10.1053/j.gastro.2016.11.027. Epub 2016 Nov 23. No abstract available.

PMID:
27889571
26.

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Rex DK.

Gastroenterology. 2017 Apr;152(5):1217-1237.e3. doi: 10.1053/j.gastro.2016.08.053. Epub 2016 Oct 19. Review.

PMID:
27769517
27.

Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer.

Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Rex DK.

Gastrointest Endosc. 2017 Jan;85(1):2-21.e3. doi: 10.1016/j.gie.2016.09.025. Epub 2016 Oct 18. Review. No abstract available.

PMID:
27769516
28.

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Rex DK.

Am J Gastroenterol. 2017 Jan;112(1):37-53. doi: 10.1038/ajg.2016.492. Epub 2016 Oct 18. Review.

PMID:
27753435
29.

Exportin-5 Functions as an Oncogene and a Potential Therapeutic Target in Colorectal Cancer.

Shigeyasu K, Okugawa Y, Toden S, Boland CR, Goel A.

Clin Cancer Res. 2017 Mar 1;23(5):1312-1322. doi: 10.1158/1078-0432.CCR-16-1023. Epub 2016 Aug 23.

30.

Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes.

Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez ME, Alberts DS, Lance P.

J Natl Cancer Inst. 2016 Aug 16;108(12). pii: djw152. doi: 10.1093/jnci/djw152. Print 2016 Dec.

31.

Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial.

Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow SH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez EM, Alberts DS, Lance P.

J Natl Cancer Inst. 2016 Aug 16;108(12). pii: djw151. doi: 10.1093/jnci/djw151. Print 2016 Dec.

32.

Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.

Lowery JT, Ahnen DJ, Schroy PC 3rd, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R.

Cancer. 2016 Sep 1;122(17):2633-45. doi: 10.1002/cncr.30080. Epub 2016 Jun 3. Review. Erratum in: Cancer. 2017 Oct 1;123(19):3857.

33.

Novel Mutations in MLH1 and MSH2 Genes in Mexican Patients with Lynch Syndrome.

Moreno-Ortiz JM, Ayala-Madrigal Mde L, Corona-Rivera JR, Centeno-Flores M, Maciel-Gutiérrez V, Franco-Topete RA, Armendáriz-Borunda J, Hotchkiss E, Pérez-Carbonell L, Rhees J, Boland CR, Gutiérrez-Angulo M.

Gastroenterol Res Pract. 2016;2016:5278024. doi: 10.1155/2016/5278024. Epub 2016 May 10.

34.

Recent discoveries in the molecular genetics of Lynch syndrome.

Boland CR.

Fam Cancer. 2016 Jul;15(3):395-403. doi: 10.1007/s10689-016-9885-5.

PMID:
27038793
35.

Correspondence: Reply to 'SEMA4A variation and risk of colorectal cancer'.

Sill H, Schulz E, Steinke-Lange V, Boland CR.

Nat Commun. 2016 Mar 10;7:10695. doi: 10.1038/ncomms10695. No abstract available.

36.

Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.

Kahi CJ, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Robertson DJ, Rex DK; United States Multi-Society Task Force on Colorectal Cancer.

Gastroenterology. 2016 Mar;150(3):758-768.e11. doi: 10.1053/j.gastro.2016.01.001. Epub 2016 Feb 10. Review.

PMID:
26892199
37.

Colonoscopy Surveillance after Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.

Kahi CJ, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Robertson DJ, Rex DK.

Am J Gastroenterol. 2016 Mar;111(3):337-46; quiz 347. doi: 10.1038/ajg.2016.22. Epub 2016 Feb 12.

PMID:
26871541
38.

Colonoscopy surveillance after colorectal cancer resection: recommendations of the US multi-society task force on colorectal cancer.

Kahi CJ, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Robertson DJ, Rex DK.

Gastrointest Endosc. 2016 Mar;83(3):489-98.e10. doi: 10.1016/j.gie.2016.01.020. Epub 2016 Jan 21. Review. No abstract available.

PMID:
26802191
39.

Prognostic Subgroups among Patients with Stage II Colon Cancer.

Boland CR, Goel A.

N Engl J Med. 2016 Jan 21;374(3):277-8. doi: 10.1056/NEJMe1514353.

40.

Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.

Koi M, Garcia M, Choi C, Kim HR, Koike J, Hemmi H, Nagasaka T, Okugawa Y, Toiyama Y, Kitajima T, Imaoka H, Kusunoki M, Chen YH, Mukherjee B, Boland CR, Carethers JM.

Gastroenterology. 2016 Apr;150(4):944-55. doi: 10.1053/j.gastro.2015.12.032. Epub 2016 Jan 2.

41.

Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.

Hur K, Toiyama Y, Okugawa Y, Ide S, Imaoka H, Boland CR, Goel A.

Gut. 2017 Apr;66(4):654-665. doi: 10.1136/gutjnl-2014-308737. Epub 2015 Dec 23.

42.

Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.

Okugawa Y, Toiyama Y, Toden S, Mitoma H, Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.

Gut. 2017 Jan;66(1):107-117. doi: 10.1136/gutjnl-2015-309359. Epub 2015 Oct 15.

43.

Genetics and Genetic Testing in Hereditary Colorectal Cancer.

Stoffel EM, Boland CR.

Gastroenterology. 2015 Oct;149(5):1191-1203.e2. doi: 10.1053/j.gastro.2015.07.021. Epub 2015 Jul 27. Review.

PMID:
26226567
44.

Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.

Yamada A, Horimatsu T, Okugawa Y, Nishida N, Honjo H, Ida H, Kou T, Kusaka T, Sasaki Y, Yagi M, Higurashi T, Yukawa N, Amanuma Y, Kikuchi O, Muto M, Ueno Y, Nakajima A, Chiba T, Boland CR, Goel A.

Clin Cancer Res. 2015 Sep 15;21(18):4234-42. doi: 10.1158/1078-0432.CCR-14-2793. Epub 2015 Jun 2.

45.

MiR-320e is a novel prognostic biomarker in colorectal cancer.

Perez-Carbonell L, Sinicrope FA, Alberts SR, Oberg AL, Balaguer F, Castells A, Boland CR, Goel A.

Br J Cancer. 2015 Jun 30;113(1):83-90. doi: 10.1038/bjc.2015.168. Epub 2015 Jun 2.

46.

PMS2 monoallelic mutation carriers: the known unknown.

Goodenberger ML, Thomas BC, Riegert-Johnson D, Boland CR, Plon SE, Clendenning M, Win AK, Senter L, Lipkin SM, Stadler ZK, Macrae FA, Lynch HT, Weitzel JN, de la Chapelle A, Syngal S, Lynch P, Parry S, Jenkins MA, Gallinger S, Holter S, Aronson M, Newcomb PA, Burnett T, Le Marchand L, Pichurin P, Hampel H, Terdiman JP, Lu KH, Thibodeau S, Lindor NM.

Genet Med. 2016 Jan;18(1):13-9. doi: 10.1038/gim.2015.27. Epub 2015 Apr 9. Review.

47.

Pitfalls in the diagnosis of biallelic PMS2 mutations.

Antelo M, Milito D, Rhees J, Roca E, Barugel M, Cuatrecasas M, Moreira L, Leoz ML, Carballal S, Ocaña T, Pellisé M, Castells A, Boland CR, Goel A, Balaguer F.

Fam Cancer. 2015 Sep;14(3):411-4. doi: 10.1007/s10689-015-9793-0.

PMID:
25773960
48.

Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers.

Wei C, Peng B, Han Y, Chen WV, Rother J, Tomlinson GE, Boland CR, Chaussabel D, Frazier ML, Amos CI.

Fam Cancer. 2015 Jun;14(2):297-306. doi: 10.1007/s10689-014-9758-8. Erratum in: Fam Cancer. 2015 Jun;14(2):307. Chaussabel, Marc [corrected to Chaussabel, Damien].

49.

Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer.

Toden S, Okugawa Y, Buhrmann C, Nattamai D, Anguiano E, Baldwin N, Shakibaei M, Boland CR, Goel A.

Cancer Prev Res (Phila). 2015 May;8(5):431-43. doi: 10.1158/1940-6207.CAPR-14-0354. Epub 2015 Feb 23.

50.

Supplemental Content

Loading ...
Support Center